0000000000384731

AUTHOR

Myriam Martel

showing 5 related works from this author

Relative risk rather than absolute risk reduction should be preferred to sensitise the public to preventive actions.

2021

We thank Lawrence and colleagues1 for their interest in our work,2 about which they raised some comments as the need of expressing results in absolute rather than relative risks. As they appropriately mentioned in their correspondence, absolute risk is an important parameter for the estimation of the effect of an intervention and must sometimes be preferred to relative risk. However, when discussing with health professionals and policymakers, using absolute risk reductions, expressed as percentages, may incorrectly lead to an intervention being considered unnecessary. As example, what would be the point of reducing by 30% the occurrence of an event affecting 2% of the population? This is ex…

0301 basic medicineEstimationRiskeducation.field_of_studyActuarial scienceCancer preventionCoronavirus disease 2019 (COVID-19)PopulationGastroenterologyAbsolute risk reductionDiscount points03 medical and health sciences030104 developmental biology0302 clinical medicineIntervention (counseling)Relative riskHumans030211 gastroenterology & hepatologyeducationPsychologyNumbers Needed To TreatGut
researchProduct

PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate: A Cost-Effectiveness Analysis

2011

SucralfateHistamine H2 receptorbusiness.industryAnesthesiaStress ulcerHealth PolicyPublic Health Environmental and Occupational HealthMedicineCost-effectiveness analysisbusinessmedicine.diseasehealth care economics and organizationsmedicine.drugValue in Health
researchProduct

Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis

2012

Background Routine second-look endoscopy in modern-era peptic ulcer bleeding (PUB) remains controversial. Objective To assess the effectiveness of routine second-look endoscopy in patients with PUB exhibiting high-risk stigmata after standard medical care and endoscopic therapy. Design Comprehensive literature searches (1990-2011) were performed, seeking randomized trials comparing a routine with an as-needed second endoscopy. Main Outcome Measurements The main outcome was rebleeding. Secondary outcomes were surgery and mortality. Subanalyses assessed the influence of study quality, rebleeding definitions, endoscopic hemostasis modality, and proton pump inhibitor (PPI) therapies. Analyses w…

Riskmedicine.medical_specialtymedicine.drug_classMEDLINEProton-pump inhibitorlaw.inventionRandomized controlled trialRecurrencelawOdds RatiomedicineHumansRadiology Nuclear Medicine and imagingModels Statisticalmedicine.diagnostic_testbusiness.industryHemostasis EndoscopicGastroenterologyProton Pump InhibitorsOdds ratioConfidence intervalSurgeryEndoscopyPeptic Ulcer HemorrhageTreatment OutcomeMeta-analysisHemostasisbusinessGastrointestinal Endoscopy
researchProduct

Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal …

2011

Aliment Pharmacol Ther 2011; 33: 1010–1018 Summary Background  The prognostic value of an elevated international normalised ratio (INR) as part of initial risk stratification in nonvariceal upper gastrointestinal bleeding (NVUGIB) remains poorly characterised. Aim  To assess the usefulness of the initial INR in patients with NVUGIB. Method  After a systematic review, we included the presenting INR and other validated prognosticators in multivariable models predicting rebleeding and mortality. Data are reported as odd ratios and 95% confidence intervals. Results  Only two of 769 candidate studies were useful, but reported disparate, highly selected NVUGIB patients with varying threshold init…

endocrine systemGastrointestinal bleedingmedicine.medical_specialtyHepatologybusiness.industryfungiGastroenterologyMean agemedicine.diseaseConfidence intervalSurgeryhealth services administrationInternal medicineCohortmedicineInternational normalised ratioheterocyclic compoundsPharmacology (medical)In patientcardiovascular diseasesUpper gastrointestinal bleedingYoung adultbusinessAlimentary Pharmacology & Therapeutics
researchProduct

Cost-Effectiveness Analysis: Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists

2012

Abstract Objectives Proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs) present varying pharmacological efficacy in preventing stress ulcer bleeding (SUB) in intensive care units. The literature also reports disparate rates of ventilator-assisted pneumonia (VAP) as side effects of these treatments. We compared the cost-effectiveness of these two prophylactic pharmacological options. Methods We constructed a decision tree with a 60-day time horizon for patients at high risk for developing SUB, receiving either PPIs or H2RAs. For each treatment strategy, patients could be in one of three states of health: SUB, VAP, or no complication. Contemporary, clinically relevant probabilit…

Peptic Ulcermedicine.medical_specialtyMultivariate analysisDatabases FactualCost effectivenessmedicine.drug_classCost-Benefit AnalysisMEDLINEProton-pump inhibitorH2RAIntensive careInternal medicinemedicineHumanscost-effectivenessbusiness.industryHealth PolicyStress ulcerDecision TreesPublic Health Environmental and Occupational HealthProton Pump InhibitorsHealth Care CostsCost-effectiveness analysisLength of StayAnti-Ulcer Agentsmedicine.diseaseUnited StatesSurgerystress ulcer bleedingHistamine H2 AntagonistsMultivariate AnalysisGastrointestinal HemorrhagebusinessComplicationValue in Health
researchProduct